Related references
Note: Only part of the references are listed.Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
Alessandro Mantovani et al.
GUT (2022)
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover
Yuki Tanaka et al.
GUT (2021)
The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population
Pai-Feng Hsu et al.
LIVER INTERNATIONAL (2021)
Redefining fatty liver disease: an international patient perspective
Gamal Shiha et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
Hokyou Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events
Jie Xu et al.
STROKE (2021)
MAFLD and risk of CKD
Dan-Qin Sun et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Risk of Kidney Dysfunction in NAFLD
Alessandro Mantovani et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes
Rosa Lombardi et al.
LIVER INTERNATIONAL (2020)
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
Stefano Romeo et al.
CELL METABOLISM (2020)
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review
Rohit Loomba et al.
GASTROENTEROLOGY (2020)
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter et al.
GASTROENTEROLOGY (2020)
Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study
Hye Won Lee et al.
HEPATOLOGY (2020)
Update on NAFLD genetics: From new variants to the clinic
Eric Trepo et al.
JOURNAL OF HEPATOLOGY (2020)
Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score
Zhuojun Xin et al.
LIVER INTERNATIONAL (2020)
The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management
Genoveva Berna et al.
LIVER INTERNATIONAL (2020)
Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features
Vanessa Bullon-Vela et al.
NUTRITION (2020)
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data
Rohit Loomba et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease
Leonard Kaps et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes
Rosa Lombardi et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2020)
Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice
Salvador Augustin et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2020)
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin et al.
LIVER INTERNATIONAL (2020)
Association between non-alcoholic fatty liver and acute cerebral infarction: a protocol of systematic review and meta-analysis
Ya-Juan Zhang et al.
MEDICINE (2020)
Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease
Avik Majumdar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients
Ye Seul Bae et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: Un Affaire de Coeur
Abdulrahman Ismaiel et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations
Ramesh Kumar et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2020)
The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials
Seyedeh Parisa Moosavian et al.
CLINICAL NUTRITION ESPEN (2020)
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses
Jaehee Ahn et al.
CLINICAL NUTRITION (2019)
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair Younossi et al.
HEPATOLOGY (2019)
Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease
Serena Pelusi et al.
LIVER INTERNATIONAL (2019)
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study
Ferdinando Carlo Sasso et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study
Celestino Sardu et al.
DIABETES CARE (2019)
Nonalcoholic Fatty Liver Disease Is Associated With Arterial Distensibility and Carotid Intima-Media Thickness: (from the Multi-Ethnic Study of Atherosclerosis)
Ebenezer Oni et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
Soumik BasuRay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
Jun-Ke Long et al.
MOLECULAR MEDICINE (2019)
Genetic Insights for Drug Development in NAFLD
Mohammed Eslam et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry)
Paolo Calabro et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
Harald Mangge et al.
MOLECULES (2019)
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study
F. C. Sasso et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2019)
Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
Ludovico Abenavoli et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Myriam Alexander et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease
Robert N. Helsley et al.
ELIFE (2019)
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients
Marco Vincenzo Lenti et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae (vol 30, pg 675, 2019)
Jing Yuan et al.
CELL METABOLISM (2019)
Insulin resistance: Review of the underlying molecular mechanisms
Habib Yaribeygi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease
Ze Chen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered
Maria Corina Plaz Torres et al.
NUTRIENTS (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
P. Dongiovanni et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy
A. Marrone et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms
Valeria Tosti et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2018)
Type 1 diabetes: Through the lens of human genome and metagenome interplay
Sepideh Zununi Vahed et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Steven J. Forrester et al.
CIRCULATION RESEARCH (2018)
PBDEs Altered Gut Microbiome and Bile Acid Homeostasis in Male C57BL/6 Mice
Cindy Yanfei Li et al.
DRUG METABOLISM AND DISPOSITION (2018)
Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure
Filippo Valbusa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Metagenomics Analysis of Gut Microbiota in a High Fat Diet-Induced Obesity Mouse Model Fed with (-)-Epigallocatechin 3-O-(3-O-Methyl) Gallate (EGCG3Me)
Xin Zhang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies
Roberto Minutolo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts
R. Estruch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
Mario Masarone et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Mediterranean diet and nonalcoholic fatty liver disease
Caterina Anania et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients
Rosa Zampino et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2018)
Impact of a 3-Months Vegetarian Diet on the Gut Microbiota and Immune Repertoire
Chenchen Zhang et al.
FRONTIERS IN IMMUNOLOGY (2018)
The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C
Luigi Elio Adinolfi et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2018)
Oxidative stress in chronic lung disease: From mitochondrial dysfunction to dysregulated redox signaling
Albert van der Vliet et al.
MOLECULAR ASPECTS OF MEDICINE (2018)
Does the Mediterranean Diet Protect against Stress-Induced Inflammatory Activation in European Adolescents? The HELENA Study
Kenia M. B. Carvalho et al.
NUTRIENTS (2018)
Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases
Abdellah Mansouri et al.
GASTROENTEROLOGY (2018)
Effect of a low glycemic index Mediterranean diet on non-alcoholic fatty liver disease. A randomized controlled clinici trial
G. Misciagna et al.
JOURNAL OF NUTRITION HEALTH & AGING (2017)
The PNPLA3 Variant Associated With Fatty Liver Disease (I148M) Accumulates on Lipid Droplets by Evading Ubiquitylation
Soumik BasuRay et al.
HEPATOLOGY (2017)
Electrophysiological Adverse Effects of Direct Acting Antivirals in Patients With Chronic Hepatitis C
Emanuele Durante-Mangoni et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
Ryuki Hashida et al.
JOURNAL OF HEPATOLOGY (2017)
Treatment of NAFLD with diet, physical activity and exercise
Manuel Romero-Gómez et al.
JOURNAL OF HEPATOLOGY (2017)
Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease
Chiara Gelli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Nonalcoholic fatty liver disease: Evolving paradigms
Amedeo Lonardo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
Luca Rinaldi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases
Nima Motamed et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Linking resistin, inflammation, and cardiometa-bolic diseases
Hyeong Kyu Park et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2017)
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
Mario Masarone et al.
PLOS ONE (2017)
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens
Nicola Coppola et al.
ANTIVIRAL THERAPY (2017)
Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance
Francesco Baratta et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Seasonal variations of hyponatremia in the emergency department: Age-related changes
Mauro Giordano et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2017)
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: identification of eleven novel pathogenic sequence variants
Gabriella Esposito et al.
BMC MEDICAL GENETICS (2017)
Insulin Signalling: The Inside Story
Barry I. Posner
CANADIAN JOURNAL OF DIABETES (2017)
CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics: A clinical trial comparing the efficacy of a Mediterranean diet rich in olive oil versus a low-fat diet on cardiovascular disease in coronary patients
Javier Delgado-Lista et al.
AMERICAN HEART JOURNAL (2016)
Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children
David E. Kleiner et al.
CLINICS IN LIVER DISEASE (2016)
Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice
Yanbo Fan et al.
GASTROENTEROLOGY (2016)
Serial Liver Stiffness Measurements and Monitoring of Liver-Transplanted Patients in a Real-Life Clinical Practice
Luca Rinaldi et al.
HEPATITIS MONTHLY (2016)
Diet, Weight Loss, and Liver Health in Nonalcoholic Fatty Liver Disease: Pathophysiology, Evidence, and Practice
Giulio Marchesini et al.
HEPATOLOGY (2016)
The rs2294918 E434K Variant Modulates Patatin-Like Phospholipase Domain-Containing 3 Expression and Liver Damage
Benedetta Donati et al.
HEPATOLOGY (2016)
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis
Piero Pingitore et al.
HUMAN MOLECULAR GENETICS (2016)
Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins
Eriks Smagris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Exercise Training Reduces Liver Fat and Increases Rates of VLDL Clearance But Not VLDL Production in NAFLD
F. Shojaee-Moradie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2016)
The role of the gut microbiota in NAFLD
Christopher Leung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions
Maria Grazia Clemente et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease A Randomized Clinical Trial
Hui-Jie Zhang et al.
JAMA INTERNAL MEDICINE (2016)
Lifestyle changes and cardiovascular risk reduction in diabetes
Matti Uusitupa
LANCET DIABETES & ENDOCRINOLOGY (2016)
Nonalcoholic Fatty Liver Disease and Vascular Function Cross-Sectional Analysis in the Framingham Heart Study
Michelle T. Long et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men
Kadir Ozturk et al.
ATHEROSCLEROSIS (2015)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Relationship of sitting time and physical activity with non-alcoholic fatty liver disease
Seungho Ryu et al.
JOURNAL OF HEPATOLOGY (2015)
Effect of aerobic exercise training dose on liver fat and visceral adiposity
Shelley E. Keating et al.
JOURNAL OF HEPATOLOGY (2015)
PNPLA3 1148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity
Alison Mondul et al.
JOURNAL OF NUTRITION (2015)
Proteobacteria: microbial signature of dysbiosis in gut microbiota
Na-Ri Shin et al.
TRENDS IN BIOTECHNOLOGY (2015)
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells
Carminia Maria Della Corte et al.
Oncotarget (2015)
Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
Muejdat Zeybel et al.
CLINICAL EPIGENETICS (2015)
Epigenetics in the development, modification, and prevention of cardiovascular disease
Thomas F. Whayne
MOLECULAR BIOLOGY REPORTS (2015)
Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis
Yoko Takaki et al.
CANCER SCIENCE (2014)
Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans
M. Miriam Jacome-Sosa et al.
CURRENT OPINION IN LIPIDOLOGY (2014)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
Carlo Pirazzi et al.
HUMAN MOLECULAR GENETICS (2014)
Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet
Li-jun Wang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
Julia Kozlitina et al.
NATURE GENETICS (2014)
TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content
Hovsep Mahdessian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Lysophospholipid acyltransferases and eicosanoid biosynthesis in zebrafish myeloid cells
Simona Zarini et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2014)
SIRT1 and other sirtuins in metabolism
Hung-Chun Chang et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition
Joo Ho Lee et al.
NUTRIENTS (2014)
Carbonic Anhydrase Activation Is Associated With Worsened Pathological Remodeling in Human Ischemic Diabetic Cardiomyopathy
Daniele Torella et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Endocan (ESM-1): a novel soluble endothelial cell injury marker in preeclampsia (PE) and intrauterine growth restriction (IUGR)
Sarah Cross et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Free radical biology for medicine: learning from nonalcoholic fatty liver disease
Gaetano Serviddio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Identification of small subunit of serine palmitoyltransferase a as a lysophosphatidylinositol acyltransferase 1-interacting protein
Yusuke Hirata et al.
GENES TO CELLS (2013)
Non-alcoholic fatty liver disease and cardiovascular risk
Angel Brea et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Maternal Methyl Donors Supplementation during Lactation Prevents the Hyperhomocysteinemia Induced by a High-Fat-Sucrose Intake by Dams
Paul Cordero et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
Akinobu Takaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity
Alexander R. Moschen et al.
JOURNAL OF HEPATOLOGY (2013)
Adherence to Mediterranean diet reduces the risk of metabolic syndrome: A 6-year prospective study
E. Kesse-Guyot et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2013)
PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma
Luca Valenti et al.
PLOS ONE (2013)
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
Giovanni Musso et al.
PROGRESS IN LIPID RESEARCH (2013)
Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplant Patients: Effectiveness in a Real-World Setting
G. Valente et al.
TRANSPLANTATION PROCEEDINGS (2013)
PNPLA3 I148M polymorphism and progressive liver disease
Paola Dongiovanni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Anabela P. Rolo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome
Anne Vrieze et al.
GASTROENTEROLOGY (2012)
The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites
Luke K. Ursell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Peri-Procedural Tight Glycemic Control during Early Percutaneous Coronary Intervention Is Associated with a Lower Rate of In-Stent Restenosis in Patients with Acute ST-Elevation Myocardial Infarction
Raffaele Marfella et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease
Jenni Hyysalo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
Carlo Pirazzi et al.
JOURNAL OF HEPATOLOGY (2012)
Methyl donor deficiency impairs fatty acid oxidation through PGC-1α hypomethylation and decreased ER-α, ERR-α, and HNF-4α in the rat liver
Shabnam Pooya et al.
JOURNAL OF HEPATOLOGY (2012)
Functional interactions between the gut microbiota and host metabolism
Valentina Tremaroli et al.
NATURE (2012)
Gut-liver axis: The impact of gut microbiota on non alcoholic fatty liver disease
D. Compare et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2012)
Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
Marcos Pasarin et al.
PLOS ONE (2012)
Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitis
Sema Uysal et al.
CLINICAL BIOCHEMISTRY (2011)
Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency
Melanie D. Spencer et al.
GASTROENTEROLOGY (2011)
Meta-Analysis of the Influence of I148M Variant of Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) on the Susceptibility and Histological Severity of Nonalcoholic Fatty Liver Disease
Silvia Sookoian et al.
HEPATOLOGY (2011)
Innate Immune Activity in Plaque of Patients with Untreated and L-Thyroxine-Treated Subclinical Hypothyroidism
Raffaele Marfella et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Macrophages, Inflammation, and Insulin Resistance
Jerrold M. Olefsky et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
Recent advances in nonalcoholic fatty liver disease
Onpan Cheung et al.
CURRENT OPINION IN GASTROENTEROLOGY (2010)
Insulin Resistance in Nonalcoholic Fatty Liver Disease
E. Bugianesi et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
High-Mobility Group Box-1 Protein Promotes Angiogenesis After Peripheral Ischemia in Diabetic Mice Through a VEGF-Dependent Mechanism
Federico Biscetti et al.
DIABETES (2010)
A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
Shaoqing He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Vertebrate Endoderm Development and Organ Formation
Aaron M. Zorn et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2009)
Vascular endothelium in atherosclerosis
Anca V. Sima et al.
CELL AND TISSUE RESEARCH (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Apoptosis and Cytokinesin Non-Alcoholic Steatohepatitis
Wing-Kin Syn et al.
CLINICS IN LIVER DISEASE (2009)
Non-alcoholic fatty liver disease pathogenesis: The present and the future
S. Petta et al.
DIGESTIVE AND LIVER DISEASE (2009)
Microbes in Gastrointestinal Health and Disease
Andrew S. Neish
GASTROENTEROLOGY (2009)
The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver
Nicola L. Beer et al.
HUMAN MOLECULAR GENETICS (2009)
Molecular mechanisms involved in NAFLD progression
Mariano Malaguarnera et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Carotid artery intima-media thickness in nonalcoholic fatty liver disease
Anna Ludovica Fracanzani et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Fatty liver - A novel component of the metabolic syndrome
Anna Kotronen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Metabolic syndrome pandemic
Scott M. Grundy
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study
Naomi M. Hamburg et al.
CIRCULATION (2008)
Causes and Metabolic Consequences of Fatty Liver
Norbert Stefan et al.
ENDOCRINE REVIEWS (2008)
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice
Mathieu Membrez et al.
FASEB JOURNAL (2008)
Nonalcoholic Steatohepatitis Is Associated with Altered Hepatic MicroRNA Expression
Onpan Cheung et al.
HEPATOLOGY (2008)
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
Catherine Postic et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Genetic and environmental interactions in obesity and type 2 diabetes
Isabela Romao et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2008)
Adipokines and the peripheral and neural control of energy balance
Rexford S. Ahima et al.
MOLECULAR ENDOCRINOLOGY (2008)
Nonalcoholic fatty liver disease: Pathogenesis and potential for nuclear receptors as therapeutic targets
Jacob George et al.
MOLECULAR PHARMACEUTICS (2008)
The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes
Raffaele Marfella et al.
CARDIOVASCULAR DIABETOLOGY (2007)
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
Giovanni Targher et al.
DIABETES CARE (2007)
Effect of a single high-fat meat on endothelial function in patients with the metabolic syndrome:: Role of tumor necrosis factor-α
Katherine Esposito et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2007)
Metabolism of linoleic acid by human gut bacteria: Different routes for biosynthesis of conjugated linoleic acid
Estelle Devillard et al.
JOURNAL OF BACTERIOLOGY (2007)
Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China
Zhongli Wang et al.
POSTGRADUATE MEDICAL JOURNAL (2007)
Hepatic tumor necrosis factor signaling and nuclear factor-kappa B: Effects on liver homeostasis and beyond
Andy Wullaert et al.
ENDOCRINE REVIEWS (2007)
Microbial ecology - Human gut microbes associated with obesity
Ruth E. Ley et al.
NATURE (2006)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings
Roberto Minutolo et al.
JOURNAL OF HYPERTENSION (2006)
FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity
QW Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice
K Tomita et al.
GUT (2006)
Endocan, a new endothelial marker in human sepsis
A Scherpereel et al.
CRITICAL CARE MEDICINE (2006)
Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
K Begriche et al.
MITOCHONDRION (2006)
Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance
Herbert Tilg et al.
GASTROENTEROLOGY (2006)
Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes
GS Hotamisligil
DIABETES (2005)
Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats
F Armutcu et al.
CLINICAL BIOCHEMISTRY (2005)
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
DS Cai et al.
NATURE MEDICINE (2005)
Hepatocyte apoptosis, expression of death receptors, and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients
PS Ribeiro et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis
AE Feldstein et al.
GASTROENTEROLOGY (2003)
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
BA Neuschwander-Tetri et al.
HEPATOLOGY (2003)
Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction
TJ Anderson
HEART FAILURE REVIEWS (2003)
Nonalcoholic Steatosis and Steatohepatitis - IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines
AM Diehl
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)
Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
J Crespo et al.
HEPATOLOGY (2001)
Insulin resistance: definition and consequences
HE Lebovitz
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2001)
Role of LXRs in control of lipogenesis
JR Schultz et al.
GENES & DEVELOPMENT (2000)
Insulin: understanding its action in health and disease
P Sonksen et al.
BRITISH JOURNAL OF ANAESTHESIA (2000)
Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells
S Goetze et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
Cloning of the novel gene TM6SF1 reveals conservation of clusters of paralogous genes be tween human chromosomes 15q24 -> q26 and 19p13.3 -> p12
L Carim-Todd et al.
CYTOGENETICS AND CELL GENETICS (2000)